Companies: 10,795·Total market cap: $144.5T
Cassava Sciences, Inc.

Cassava Sciences, Inc.

SAVANASDAQHealthcare
$1.32
+$0.03(+2.33%)
Market Cap$63766423
P/E Ratio
52W High$4.98
52W Low$1.15

Cassava Sciences, Inc.(SAVA)股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

sava · 股价预测 · 12 位分析师(近3月)· FMP · 更新于 2026年3月21日

分析师评级与共识

基于过去 3 个月内 12 位华尔街分析师

SellBuy

Buy

12 位分析师

共识

评级分布

Strong Buy
0
Buy
8
Hold
4
Sell
0
Strong Sell
0
合计: 12 · 买入占比: 66.7%

12 个月目标价

High

$0.00

Consensus

$0.00

+0.0% upside

Low

$0.00

Median: $0 · Last Close: $1.32

Cassava Sciences, Inc.(SAVA)的分析师共识为 Buy,基于过去 3 个月内 12 位华尔街分析师的评级。SAVA 的 12 个月平均目标价为 $0.00,相对当前价 $1.32 代表 +0.0% 的潜在上行空间。

短期股价预测

Bear

算法生成 · 每日更新

DatePredicted PriceChange
2026-06-10$1.384.28%

1-day model range: $1.36–$1.39. Peak: $1.39 (+4.28%).

长期股价预测

⚠️ 在满 252 个交易日历史(IPO/上市时间较短)前不展示长期预测;短期标签页仍可能显示模型输出。

基于技术分析的股价预测

14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明

Market Sentiment

BEARISH

Based on 14 technical indicators

0%21%79%
0Buy
3Neutral
11Sell
RSI (14)60.3Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · SAVA · Jun 9, 2026

Simple Moving Average (SMA)
MA 5$1.40SELL
MA 10$1.43SELL
MA 20$1.33SELL
MA 50$1.53SELL
MA 100$1.82SELL
MA 200$0.00NEUTRAL
Current $SAVA · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$1.39SELL
EMA 10$1.39SELL
EMA 20$1.40SELL
EMA 50$1.55SELL
EMA 100$1.90SELL
EMA 200$0.00NEUTRAL
Current $SAVA · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
HC Wainwright & Co.2025-03-25
Maintains
NeutralNeutral
HC Wainwright & Co.2025-03-04
Maintains
NeutralNeutral
HC Wainwright & Co.2024-11-26
Downgrade ↓
BuyNeutral
HC Wainwright & Co.2024-11-08
Maintains
BuyBuy
HC Wainwright & Co.2024-10-08
Upgrade ↑
NeutralBuy
Rodman & Renshaw2024-08-08
Maintains
BuyBuy
Jones Trading2024-07-01
Downgrade ↓
BuyHold
HC Wainwright & Co.2024-07-01
Downgrade ↓
BuyNeutral
HC Wainwright & Co.2024-05-17
Maintains
BuyBuy
HC Wainwright & Co.2024-03-05
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on Cassava Sciences, Inc. (SAVA) stock. Of the recent 35 rating actions, 3 were upgrades and 7 were downgrades. 12 analysts currently cover SAVA.

分析师推荐趋势

Buy ratings101
Hold ratings02↑ +2
Sell ratings00

SAVA analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.

财务预测:EPS 与营收一致预期

Revenue This Year

$100M

Revenue Next Year

$50M

↓ 50.0% YoY

EPS This Year

$-0.86

EPS Next Year

$-1.93

↑ 123.6% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast SAVA EPS of $-0.86 for the current fiscal year, based on estimates from 1 analysts. The SAVA revenue forecast is $100M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

SAVA 股价预测由两类独立数据源支撑:来自 12 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。SAVA 的共识目标价为 $0.00(+0.0% 上行空间),分析师共识为 Buy。

SAVA 的短期预测(明日)为 $1.38(+4.28%)。

Cassava Sciences, Inc. 在 NASDAQ 上市,代码 SAVA。SAVA 在 2027 年的整体展望偏积极,在覆盖分析师中约 67% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

SAVA 预测 · 8 个问题

根据 12 位华尔街分析师,SAVA 的 12 个月平均目标价为 $0.00,最高 $0.00、最低 $0.00。若有图表,中位目标价可在上方查看。相对当前价 $1.32,隐含约 +0.0% 的上行空间。

SAVA 目标价SAVA 分析师目标价SAVA 12个月目标价目标价 SAVA

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.